We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
- Authors
Aballéa, Samuel; Chancellor, Jeremy; Martin, Monique; Wutzler, Peter; Carrat, Fabrice; Gasparini, Roberto; Toniolo-Neto, Joao; Drummond, Michael; Weinstein, Milton
- Abstract
Routine influenza vaccination is currently recommended in several countries for people aged more than 60 or 65 years or with high risk of complications. A lower age threshold of 50 years has been recommended in the United States since 1999. To help policymakers consider whether such a policy should be adopted more widely, we conducted an economic evaluation of lowering the age limit for routine influenza vaccination to 50 years in Brazil, France, Germany, and Italy.
- Publication
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2007, Vol 10, Issue 2, p98
- ISSN
1098-3015
- Publication type
Journal Article
- DOI
10.1111/j.1524-4733.2006.00157.x